Infectious Diseases and Global Health

Basic definition of infection refers to the harm caused by pathogenic microorganisms such as bacteria, viruses, fungi, parasites, or other infectious agents entering the human body. Some infections are mild, while others can be severe or life-threatening depending on the type of organism involved. From understanding the causes, symptoms, pathogen detection, clinical studies, treatment strategies, infection prevention and control, antimicrobial resistance, vaccine development, novel diagnostic technologies, and innovative therapeutic approaches, participants can discuss the latest scientific advancements at our upcoming Infectious Diseases Conference.

The global infectious diseases market continues to witness remarkable growth due to the increasing burden of emerging and re-emerging infections, rising antimicrobial resistance, expanding vaccine development, growing healthcare investments, and continuous advancements in diagnostic technologies. In 2025, the global infectious diseases therapeutics market was valued at approximately USD 172 billion and is projected to reach nearly USD 255 billion by 2030, growing at a CAGR of around 8.2% during the forecast period. Simultaneously, the infectious disease diagnostics market is valued at over USD 35 billion and is expected to grow steadily with the increasing adoption of molecular diagnostics, point-of-care testing, and AI-powered diagnostic platforms. North America continues to dominate the global market due to its robust healthcare infrastructure and strong research investments, while the Asia-Pacific region is anticipated to witness the fastest growth owing to increasing healthcare expenditure, improved disease surveillance, and expanding access to advanced diagnostic and treatment technologies.

ALSO READ Infectious Diseases and Global Health Viral Infections Bacterial Infections Fungal Infections Vector-borne Diseases Virology and HIVAIDS Immunology and Clinical Microbiology Antiviral Drug Resistance Catheter-Associated Urinary Tract Infection Emerging Infectious Diseases Hospital-Acquired Infections HAIs Maternal-Fetal Infections Next-Generation Antibiotics Pediatric Infectious Diseases Sepsis Diagnosis and Care Zoonotic Diseases Neurological and CNS Infections Healthcare-Associated Infections Ophthalmological Infectious Diseases Lower Respiratory and Pediatric IDs Genomics and Infectious disease Special Session on COVID-19 Vaccines and Immunizations Antibiotic Sensitivity Testing Blood-Borne Disease Contagious Disease Encephalitis Global Pandemic Preparedness Influenza Surveillance Systems Microbiome and Immunity Occupational Safety and Health OSH Point-of-Care Testing POCT Travel-Related Infections Tropical Diseases and Parasitic Diseases Sexually Transmitted Diseases and STIs Pathophysiology and Diagnosis Clinical Trials and Case Studies Influencing Factors of IDs Advanced Treatments and Technologies Oral and Maxillofacial Infections Prevention and Control Public Health and Epidemiology Artificial Intelligence in ID Climate Change and Infections Gastroenteritis HIV and Co-Infections Malaria Elimination Strategies Neglected Tropical Diseases NTDs One Health Approach Rapid Diagnostic Innovations Tuberculosis Drug Resistance

Tags
Infection Conferences 2026 Europe Infectious Disease Conferences 2026 Asia Epidemiology Conferences Infection Conferences 2026 USA Infection Conferences 2026 Infectious Diseases Conferences HIV/AIDS Conferences Infection Conferences 2027 Asia Vector-Borne Diseases Conferences Infectious Diseases Conferences Europe Bacteriology Conferences Mycology Conferences Contagious Diseases Conferences Influenza Conferences Infection Conferences 2027

+1 (506) 909-0537